Please login to the form below

Not currently logged in
Email:
Password:

Disruptive technologies set to stabilise soaring drug prices

AI and blockchain could accelerate the drug development process, says report

robot

The pharmaceutical industry has been no stranger to the rising costs of drug development as of late, but disruptive technologies could soon change this paradigm, according to a report by GlobalData.

Artificial intelligence (AI), big data and blockchain are set to impact the industry, not only by helping to add value in terms of personalised treatments, but to also counteract the unsustainability of skyrocketing drug prices, according to the data and analytics company.

The report states that there are currently over 100 companies applying AI to healthcare, with big names such as Google, Microsoft, Amazon and IBM Watson paving the way.

With the new technology, researchers are hoping to “generate more accurate hypotheses faster, making the drug discovery process less expensive and more effective”, said Valentina Gburcik, GlobalData’s cardiovascular and metabolic disease director.

She added: “In addition, the database of electronic medical records and public health data can be analysed to identify hidden patterns that can lead to a quick identification of potential molecular targets for a disease.”

And it’s not just the pharmaceutical industry that is set to see the change either. Quite recently it was reported that health insurers are also testing blockchain’s capabilities in generating more accurate and reliable demographic data, such as health records.

Gburcik concluded: “Blockchain could be a platform for sharing electronic health records between various health organisations in a secure way, which would further facilitate research and speed up the drug development process.

“Furthermore, there is a great potential for using this technology in pharmaceutical supply chain, medical billing and anonymised patient record transmission.”

Article by
Gemma Jones

1st May 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics